Pharvaris NV PHVS:NASDAQ

RT Quote | NASDAQ | USD
Last | 08/12/22 EDT
17.07quote price arrow up+0.05 (+0.29%)
Volume
117
52 week range
13.14 - 27.50
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close17.02
  • 52 Week High27.50
  • 52 Week High Date06/17/22
  • 52 Week Low13.14
  • 52 Week Low Date11/24/21

Key Stats

  • Market Cap565.87M
  • Shares Out33.15M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change18.28

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close17.02
  • 52 Week High27.50
  • 52 Week High Date06/17/22
  • 52 Week Low13.14
  • 52 Week Low Date11/24/21
  • Market Cap565.87M
  • Shares Out33.15M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change18.28

RATIOS/PROFITABILITY

  • EPS (TTM)-1.96
  • P/E (TTM)-8.70
  • Fwd P/E (NTM)-7.23
  • EBITDA (TTM)-63.52M
  • ROE (TTM)-24.72%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.12%

EVENTS

  • Earnings Date11/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Pharvaris NV

There is no recent news for this security.

Profile

MORE
Pharvaris BV is a Switzerland-based clinical-stage company. The activity of the Company focuses on producing oral bradykinin B2-receptor antagonists and is advancing new alternatives to injected therapies for all sub-types of hereditary angioedema (HAE).
Berndt Modig CPA
Chief Executive Officer, Co-Founder, Executive Director
Anna Nijdam
Head of Finance, Principal Accounting Officer
Address
J.H. Oortweg 21
Leiden
2333 CH
Netherlands

Top Peers

SYMBOLLASTCHG%CHG
AUTL
Autolus Therapeutics PLC
3.57+0.11+3.18%
OCGN
Ocugen Inc
2.84+0.16+5.97%
KZR
Kezar Life Sciences Inc
10.35+0.59+6.05%
RAPT
Rapt Therapeutics Inc
28.05+3.69+15.15%
AVTE
Aerovate Therapeutics Inc
25.79+1.93+8.09%